MARKET

FBIO

FBIO

Fortress Biotech Inc
NASDAQ
0.7200
+0.0600
+9.09%
After Hours: 0.6999 -0.0201 -2.79% 17:50 12/08 EST
OPEN
0.6696
PREV CLOSE
0.6600
HIGH
0.7250
LOW
0.6500
VOLUME
258.05K
TURNOVER
0
52 WEEK HIGH
2.870
52 WEEK LOW
0.6200
MARKET CAP
78.20M
P/E (TTM)
-0.6841
1D
5D
1M
3M
1Y
5Y
BRIEF-Checkpoint Therapeutics Announces Reverse Stock Split
Reuters · 3d ago
Journey Medical Corporation to Participate in Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech/Diagnostic Conference
SCOTTSDALE, Ariz., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for...
GlobeNewswire · 3d ago
Fortress Biotech Non-GAAP EPS of -$0.08 misses by $0.01, revenue of $16.5M misses by $5.13M
Seekingalpha · 11/15 09:13
BRIEF-Fortress Biotech Reports Third Quarter 2022 Financial Results, Recent Corporate Highlights
Reuters · 11/14 21:45
Fortress Biotech Q3 EPS $(0.18) Up From $(0.19) YoY
Benzinga · 11/14 21:36
Fortress Biotech Swings to Q3 Non-GAAP Loss, Revenue Drops
Fortress Biotech Swings to Q3 Non-GAAP Loss, Revenue Drops
MT Newswires · 11/14 16:50
-- Earnings Flash (FBIO) FORTRESS BIOTECH Posts Q3 Loss $-0.13
-- Earnings Flash (FBIO) FORTRESS BIOTECH Posts Q3 Loss $-0.13
MT Newswires · 11/14 16:23
-- Earnings Flash (FBIO) FORTRESS BIOTECH Reports Q3 Revenue $16.1M
-- Earnings Flash (FBIO) FORTRESS BIOTECH Reports Q3 Revenue $16.1M
MT Newswires · 11/14 16:23
More
About FBIO
Fortress Biotech, Inc. (Fortress) is a biopharmaceutical company that acquires, develops and commercializes pharmaceutical and biotechnology products and product candidates. Fortress has nine marketed prescription pharmaceutical products and over 30 programs in development at Fortress, and at its partner companies. Its product candidates are used in oncology, rare diseases, and gene therapy. Its commercialized products include Qbrexza, a medicated cloth towelette for the treatment of axillary hyperhidrosis; Accutane capsule is an oral retinoid indicated for the treatment of severe recalcitrant nodular acne; Ximino extended-release capsule is a tetracycline-class drug indicated to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; and Targadox is a tetracycline-class drug indicated as adjunctive therapy for severe acne. It operates in two operating and reportable segments: Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.

Webull offers kinds of Fortress Biotech Inc stock information, including NASDAQ:FBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FBIO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading FBIO stock methods without spending real money on the virtual paper trading platform.